Top Markets
Coin of the day
Immune Therapeutics, Inc. Immune Therapeutics, Inc.

Immune Therapeutics, Inc.

IMUN
Rank in Stocks #41154
Immune Therapeutics, Inc. currently conducts no significant business... Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
Share Price
$0.08
Last synced: 2023-11-13
Market Cap
$38.70K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Immune Therapeutics, Inc. (IMUN)

Category

P/S ratio for Immune Therapeutics, Inc. (IMUN)
P/S ratio as of 2026 TTM: 0
According to Immune Therapeutics, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Immune Therapeutics, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE